ATP-sensitive inward rectifier potassium channel 8 (Kir6.1) (Kir6.1)

Kir6.1-containing ATP-sensitive potassium (KATP) channels are hetero-octameric complexes composed of four pore-forming Kir6.1 subunits (encoded by the KCNJ8 gene) and four regulatory sulfonylurea receptor (SUR) subunits, typically SUR2B in vascular smooth muscle (UniProt: P48542). These channels function as metabolic sensors that couple the intracellular ATP/ADP ratio to membrane excitability, opening when ATP levels fall to hyperpolarize the cell and reduce excitability (PubMed: 23035132). In the vascular system, Kir6.1 is a primary regulator of vascular tone; its activation leads to vasodilation, while its inhibition or genetic loss-of-function can lead to vasospasm and hypertension (PubMed: 20631287). Mutations in KCNJ8 are linked to rare conditions like Cantú syndrome, characterized by hypertrichosis and cardiomegaly, as well as cardiac arrhythmia syndromes like Brugada syndrome (NCBI Gene: 3764). Pharmacological agents such as minoxidil and pinacidil act as KATP channel openers to treat hypertension, whereas sulfonylureas like glibenclamide can inhibit these channels, though they are more selective for the Kir6.2/SUR1 subtype found in the pancreas.

Other names

KCNJ8Inward rectifier potassium channel 8uKATP-1BIRKATP-1Potassium channel, inwardly rectifying subfamily J member 8KATP channel

Potassium channel openers bind to the regulatory SUR subunits of the Kir6.1 complex, increasing the probability of the channel being in an open state. This leads to an efflux of potassium ions, hyperpolarization of the plasma membrane, and a reduction in calcium influx through voltage-gated calcium channels, ultimately causing smooth muscle relaxation and vasodilation (StatPearls: NBK542333; PubMed: 23035132).